Denosumab-Induced Immune Hepatitis
Denosumab–Prolia®, Xgeva® (Amgen) is a fully human antibody to the receptor activator of the nuclear factor-K ligand (RANKL). Hepatotoxicity is extremely rare, with only one reported case of immune origin. We present a second case of hepatotoxicity resulting from an immune reaction to denosumab. A 4...
Main Authors: | Viviana Ostrovsky, Stephen Malnick, Shahar Ish-Shalom, Nadya Ziv Sokolowskaia, Ady Yosepovich, Manuela Neuman |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/9/1/76 |
Similar Items
-
Baicalin Relieves LPS-Induced Lung Inflammation via the NF-κB and MAPK Pathways
by: Bingyu Shen, et al.
Published: (2023-02-01) -
Naringenin Regulates Doxorubicin-Induced Liver Dysfunction: Impact on Oxidative Stress and Inflammation
by: Adil Farooq Wali, et al.
Published: (2020-04-01) -
The preliminary study suggests an association between NF-ĸB pathway activation and increased plasma 20S proteasome activity in intracranial aneurysm patients
by: Joanna Kamińska, et al.
Published: (2024-02-01) -
Progress and Prospects of Non-Canonical NF-κB Signaling Pathway in the Regulation of Liver Diseases
by: Li Tao, et al.
Published: (2022-07-01) -
Demethyleneberberine Protects against Hepatic Fibrosis in Mice by Modulating NF-κB Signaling
by: Yongchen Wang, et al.
Published: (2016-06-01)